Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daprodustat versus placebo in rhEPO-naive non-dialysis chronic kidney disease patients with anemia
2017-002270-39Phase 3Unknown
- Sponsor
- GSK
- Start
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in anemia of renal disease and chronic kidney disease (CKD) comparing Daprodustat with Placebo (2 arms). Primary endpoint: Mean change in hemoglobin between baseline and evaluation period. Status: unknown.
02
Drugs
daprodustat
03
Conditions
anemia of renal diseasechronic kidney disease (CKD)
Beyond the preview
Go deeper on 2017-002270-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-002270-39.